Get the app!
Back to Trades

Zeronda Tyler

DirectorCIK 0001867033

Largest Purchase

No open-market purchases in the recent filings.

Profile

Filings
5
Buy transactions
0
Sell transactions
0
Companies
1
Active
2025–2026

Across 5 filings between 2025–2026, Zeronda Tyler, Director, has disclosed $5.3M in transactions — all concentrated in Yarrow Bioscience, Inc. (YARW). Data is sourced from official SEC Form 3, 4, and 5 filings.

Trading History

5 loaded
Jul 29YARW
Yarrow Bioscience, Inc.
Zeronda TylerDirectorAward$5.3M
Jul 24VYNE
VYNE Therapeutics Inc.
Zeronda TylerInsiderTax withheld$20.2K
Jul 2VYNE
VYNE Therapeutics Inc.
Zeronda TylerInsiderTax withheld$2.3K
Jan 5VYNE
VYNE Therapeutics Inc.
Zeronda TylerInsiderTax withheld$4.6K
Oct 2VYNE
VYNE Therapeutics Inc.
Zeronda TylerInsiderTax withheld$1.1K

5 filings